Dr. Black is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2005 - 2008
- University of WashingtonResidency, Urology, 2001 - 2005
- University of WashingtonResidency, Surgery, 1999 - 2001
- Johannes Gutenberg University of Mainz Faculty of MedicineClass of 1997
Certifications & Licensure
- American Board of Urology Urology
- Royal College of Physicians and Surgeons, CanadaUrology
Clinical Trials
- Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer Start of enrollment: 2021 Sep 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin-Unresponsive N...Jacob Taylor, Ashish M Kamat, Drupad Annapureddy, Zine-Eddine Khene, Jeffrey Howard
European Urology Oncology. 2025-04-01 - Lights and Shadows of Bacillus Calmette-Guérin (BCG)-exposed and BCG-unresponsive Definitions: A Practical Overview.Luca Afferi, Andrea Gallioli, Damiano Stracci, Agostino Mattei, Christian Fankhauser
European Urology Oncology. 2025-04-01 - Can a Molecular Classifier of Upper Tract Urothelial Carcinoma Inform Clinical Decision-making and Biological Stratification?Marie-Pier St-Laurent, Jussi Nikkola, Henning Bahlburg, Joshua M Scurll, Peter C Black
European Urology. 2025-03-01
Press Mentions
- EAU 2018: Who Benefits from Neoadjuvant Chemotherapy and Who Needs Immediate Radical Treatment?March 20th, 2018
- Expert Discusses Next Steps for Durvalumab in Bladder CancerAugust 23rd, 2017
- Immune Cells the Missing Ingredient in New Bladder Cancer TreatmentJuly 24th, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: